Schmitz SF - Search Results

1

Identifying the types of missingness in quality of life data from clinical trials.

Curran D, Bacchi M, Schmitz SF, Molenberghs G, Sylvester RJ. Curran D, et al. Among authors: schmitz sf. Stat Med. 1998 Mar 15-Apr 15;17(5-7):739-56. doi: 10.1002/(sici)1097-0258(19980315/15)17:5/7<739::aid-sim818>3.0.co;2-m. Stat Med. 1998. PMID: 9549820 Review.

2

Perspectives on window of opportunity trials in head and neck cancer: lessons from the EORTC 90111-24111-NOCI-HNCG study.

Schmitz S, Caballero C, Locati LD. Schmitz S, et al. Eur J Cancer. 2018 Nov;104:219-223. doi: 10.1016/j.ejca.2018.07.315. Epub 2018 Oct 6. Eur J Cancer. 2018. PMID: 30301582

3

Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma.

Schmitz S, Machiels JP, Weynand B, Gregoire V, Hamoir M. Schmitz S, et al. Eur Arch Otorhinolaryngol. 2009 Mar;266(3):437-43. doi: 10.1007/s00405-008-0767-9. Epub 2008 Jul 22. Eur Arch Otorhinolaryngol. 2009. PMID: 18648835

4

Phase II study of sunitinib in recurrent or metastatic squamous cell carcinoma of the head and neck: GORTEC 2006-01.

Machiels JP, Henry S, Zanetta S, Kaminsky MC, Michoux N, Rommel D, Schmitz S, Bompas E, Dillies AF, Faivre S, Moxhon A, Duprez T, Guigay J. Machiels JP, et al. J Clin Oncol. 2010 Jan 1;28(1):21-8. doi: 10.1200/JCO.2009.23.8584. Epub 2009 Nov 16. J Clin Oncol. 2010. PMID: 19917865 Clinical Trial.

5

Molecular biology of squamous cell carcinoma of the head and neck: relevance and therapeutic implications.

Schmitz S, Machiels JP. Schmitz S, et al. Expert Rev Anticancer Ther. 2010 Sep;10(9):1471-84. doi: 10.1586/era.10.115. Expert Rev Anticancer Ther. 2010. PMID: 20836682 Review.

6

New advances in targeted therapies for squamous cell carcinoma of the head and neck.

Machiels JP, Schmitz S. Machiels JP, et al. Anticancer Drugs. 2011 Aug;22(7):626-33. doi: 10.1097/CAD.0b013e328341071e. Anticancer Drugs. 2011. PMID: 21048493 Review.

7

Molecular-targeted therapy of head and neck squamous cell carcinoma: beyond cetuximab-based therapy.

Machiels JP, Schmitz S. Machiels JP, et al. Curr Opin Oncol. 2011 May;23(3):241-8. doi: 10.1097/CCO.0b013e328344f581. Curr Opin Oncol. 2011. PMID: 21358328 Review.

8

Management and palliative chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck.

Machiels JP, Schmitz S. Machiels JP, et al. Expert Rev Anticancer Ther. 2011 Mar;11(3):359-71. doi: 10.1586/era.10.178. Expert Rev Anticancer Ther. 2011. PMID: 21534878 Review.

9

The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease.

Hamoir M, Ferlito A, Schmitz S, Hanin FX, Thariat J, Weynand B, Machiels JP, Grégoire V, Robbins KT, Silver CE, Strojan P, Rinaldo A, Corry J, Takes RP. Hamoir M, et al. Oral Oncol. 2012 Mar;48(3):203-10. doi: 10.1016/j.oraloncology.2011.10.015. Epub 2011 Nov 21. Oral Oncol. 2012. PMID: 22104248 Review.

10

Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).

Schmitz S, Kaminsky-Forrett MC, Henry S, Zanetta S, Geoffrois L, Bompas E, Moxhon A, Mignion L, Guigay J, Knoops L, Hamoir M, Machiels JP. Schmitz S, et al. Ann Oncol. 2012 Aug;23(8):2153-2161. doi: 10.1093/annonc/mdr574. Epub 2012 Jan 10. Ann Oncol. 2012. PMID: 22234739 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page